JPM | Free Full-Text | Short-Chain Fatty Acids in Gut–Heart Axis: Their Role in the
Pathology of Heart Failure Next Article in Journal Precision Medicine in Radiomics and …

The study of trimethylamine oxide (TMAO), a metabolite of gut microbiota, and heart failure
and chronic kidney disease has made preliminary achievements and been summarized by …

Abstract Trimethylamine-N-oxide (TMAO) is a gut microbiota-derived metabolite produced
by the action of gut microbiota and the hepatic enzyme Flavin Mono‑oxygenase 3 (FMO3) …

Background The incidence of heart failure, the terminal stage of several cardiovascular
diseases, is increasing owing to population growth and aging. Bidirectional crosstalk …

In the last few years, in the context of a growing interest in investigating novel pathways
involved in heart failure (HF) pathophysiology, the association between the gastrointestinal …

Probiotics are considered to represent important modulators of gastrointestinal health
through increased colonization of beneficial bacteria thus altering the gut microflora …

Despite significant advances in therapies, heart failure (HF) remains a progressive disease
that, once advanced, is associated with significant death and disability. Cardiac replacement …

The high incidence of atrial fibrillation (AFib) following cardiac surgery (postoperative atrial
fibrillation, POAF) relies on specific surgical features. However, in the setting of POAF, the …

Liver transplant recipients (LTRs) have lower long-term survival rates compared with the
general population. This underscores the necessity for developing biomarkers to assess …

The diversity of bacteria, viruses, eukaryotic organisms, and archaea that live in the
gastrointestinal tract and have coevolved with the host over thousands of years to establish …